SARS-CoV-2 infection as a risk factor for herpesviridae reactivation : consider the potential influence of corticosteroid therapy
| Errataetall: |
CommentOn: Crit Care. 2020 Aug 28;24(1):530. - PMID 32859241 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
|---|---|
| Enthalten in: |
Critical care (London, England) - 24(2020), 1 vom: 22. Okt., Seite 623 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Honore, Patrick M [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 26.10.2020 Date Revised 07.12.2022 published: Electronic CommentOn: Crit Care. 2020 Aug 28;24(1):530. - PMID 32859241 Citation Status MEDLINE |
|---|
| doi: |
10.1186/s13054-020-03349-9 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM316615250 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM316615250 | ||
| 003 | DE-627 | ||
| 005 | 20231225161454.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s13054-020-03349-9 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1055.xml |
| 035 | |a (DE-627)NLM316615250 | ||
| 035 | |a (NLM)33092622 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Honore, Patrick M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a SARS-CoV-2 infection as a risk factor for herpesviridae reactivation |b consider the potential influence of corticosteroid therapy |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 26.10.2020 | ||
| 500 | |a Date Revised 07.12.2022 | ||
| 500 | |a published: Electronic | ||
| 500 | |a CommentOn: Crit Care. 2020 Aug 28;24(1):530. - PMID 32859241 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Adrenal Cortex Hormones |2 NLM | |
| 700 | 1 | |a Barreto Gutierrez, Leonel |e verfasserin |4 aut | |
| 700 | 1 | |a Kugener, Luc |e verfasserin |4 aut | |
| 700 | 1 | |a Redant, Sebastien |e verfasserin |4 aut | |
| 700 | 1 | |a Attou, Rachid |e verfasserin |4 aut | |
| 700 | 1 | |a Gallerani, Andrea |e verfasserin |4 aut | |
| 700 | 1 | |a De Bels, David |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Critical care (London, England) |d 1997 |g 24(2020), 1 vom: 22. Okt., Seite 623 |w (DE-627)NLM097399787 |x 1466-609X |7 nnns |
| 773 | 1 | 8 | |g volume:24 |g year:2020 |g number:1 |g day:22 |g month:10 |g pages:623 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1186/s13054-020-03349-9 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 24 |j 2020 |e 1 |b 22 |c 10 |h 623 | ||